OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway
Zhanwei Fan, Jianjiang Dong, Yindong Mu, et al.
Bioengineered (2022) Vol. 13, Iss. 6, pp. 14670-14681
Open Access | Times Cited: 15

Showing 15 citing articles:

The Role of Adipokines in Inflammatory Mechanisms of Obesity
Tatiana V. Kirichenko, Yuliya V. Markina, Anastasia I. Bogatyreva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14982-14982
Open Access | Times Cited: 115

Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions
Jin-Ling Huo, Qi Feng, Shaokang Pan, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 51

Progress in the treatment of diabetic cardiomyopathy, a systematic review
Yiyi Shou, X M Li, Quan Fang, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 8

Association among nesfatin-1, obesity category, presence of obesity-related complications, and eating patterns in patients with obesity: results of a single endocrine centre observational study
Ewa Malwina Milewska-Kobos, Ewelina Szczepanek- Parulska, Martyna Marciniak, et al.
Peptides (2025) Vol. 185, pp. 171355-171355
Closed Access

Research Hotspots and Frontier Trends of Autophagy in Diabetic Cardiomyopathy From 2014 to 2024: A Bibliometric Analysis
Yan Mei, Shizhao Zhang, Pengpeng Liang, et al.
Journal of Multidisciplinary Healthcare (2025) Vol. Volume 18, pp. 837-860
Open Access

Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia/reperfusion injury
Tiangui Yang, Daqing Zhang
Ageing Research Reviews (2023) Vol. 86, pp. 101884-101884
Closed Access | Times Cited: 11

Oxymatrine and insulin resistance: Focusing on mechanistic intricacies involve in diabetes associated cardiomyopathy via SIRT1/AMPK and TGF‐β signaling pathway
Sanket Seksaria, Sidharth Mehan, Bhaskar Jyoti Dutta, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 5
Closed Access | Times Cited: 11

Promoting collateral formation in type 2 diabetes mellitus using ultra-small nanodots with autophagy activation and ROS scavenging
Yixuan Wang, Feifei Li, Linshuang Mao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4
Isabel Amador‐Martínez, Omar Emiliano Aparicio‐Trejo, Bismarck Bernabe-Yepes, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15875-15875
Open Access | Times Cited: 5

Nesfatin-1 regulates the phenotype transition of cavernous smooth muscle cells by activating PI3K/AKT/mTOR signaling pathway to improve diabetic erectile dysfunction
Keming Chen, Bincheng Huang, Jiajing Feng, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0304485-e0304485
Open Access | Times Cited: 1

Nesfatin-1, a novel energy-regulating peptide, alleviates pulmonary fibrosis by blocking TGF-β1/Smad pathway in an AMPKα-dependent manner
Renquan Zhang, Hui Liang, Gaoli Liu, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110369-110369
Closed Access | Times Cited: 2

Page 1

Scroll to top